Acciones Reata Pharmaceuticals, Inc.
Acciones
RETA
US75615P1030
Biotecnología e investigación médica
Último transcript sobre Reata Pharmaceuticals, Inc.
Directores | Puesto | Edad | Desde |
---|---|---|---|
J. Huff
CEO | Chief Executive Officer | 70 | 01/09/22 |
Director of Finance/CFO | 60 | 26/09/23 | |
John Hunter
IRC | Investor Relations Contact | - | - |
Administradores | Puesto | Edad | Desde |
---|---|---|---|
J. Huff
CEO | Chief Executive Officer | 70 | 01/09/22 |
Director/Board Member | - | 26/09/23 | |
Michael Dambach
BRD | Director/Board Member | - | 26/09/23 |
Nombre | Peso | AuM | Varia. 1 de ene. | Calificación inversor |
---|---|---|---|---|
0.10% | 0 M€ | 0,00 % | - | |
0.07% | 0 M€ | 0,00 % | - | |
0.05% | 773 M€ | -.--% | - | |
0.04% | 509 M€ | -.--% |
Varia. 1 de ene. | Capi. | |
---|---|---|
-2,31 % | 103 mil M | |
+0,56 % | 95,28 mil M | |
+1,69 % | 22,15 mil M | |
-17,37 % | 21,02 mil M | |
-9,30 % | 18,15 mil M | |
-41,01 % | 16,73 mil M | |
-14,85 % | 16,05 mil M | |
+3,21 % | 13,68 mil M | |
+33,54 % | 12,17 mil M |